Related Experiment Video

Updated: Nov 24, 2025

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
09:01

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection

Published on: December 10, 2013

8.1K

Role of Respiratory Syncytial Virus in Pediatric Pneumonia

Sonia Bianchini1,2, Ettore Silvestri1, Alberto Argentiero3

  • 1Department of Medicine and Surgery, University of Perugia, 06123 Perugia, Italy.

Microorganisms
|December 29, 2020
PubMed

Insights

Respiratory Syncytial Virus (RSV) causes significant infant hospitalizations and mortality globally. While new diagnostic tools emerge, effective prevention and treatment strategies for RSV remain limited due to the disease

Area of Science:

  • Pediatric Infectious Diseases
  • Respiratory Medicine
  • Virology

Background:

  • Respiratory viral infections are a primary cause of infant hospitalization and mortality worldwide.
  • Respiratory Syncytial Virus (RSV) is the leading cause of lower respiratory tract infections (LRTIs) in young children.
  • RSV infections can lead to severe complications, including respiratory failure and long-term sequelae like asthma.

Purpose of the Study:

  • To review the current landscape of Respiratory Syncytial Virus (RSV) infections in young children.
  • To highlight challenges in distinguishing RSV from other respiratory pathogens.
  • To discuss advancements in diagnostics, prophylaxis, and therapeutics for RSV.

Main Methods:

  • Review of existing literature on RSV epidemiology, clinical manifestations, and diagnostics.
  • Analysis of current treatment and prophylactic strategies, including supportive care and Palivizumab.
  • Examination of technological and scientific advancements in vaccine and drug development for RSV.

Main Results:

  • Multiplex platforms offer accurate simultaneous detection of RSV and other respiratory pathogens.
  • Current RSV treatment primarily involves supportive care; Palivizumab is the sole prophylactic option.
  • Despite scientific progress, few registered prevention or treatment strategies exist due to disease unpredictability and target population complexities.

Conclusions:

  • Accurate and rapid diagnosis of RSV is crucial for appropriate patient management.
  • Development of effective and widely applicable RSV prevention and treatment strategies remains a significant challenge.
  • Continued research is needed to overcome hurdles in targeting the specific needs of vulnerable infant populations.

Keywords:
RSVantiviral therapypneumoniarespiratory virusvaccine

More Related Videos

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses11:48

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses

Published on: April 4, 2019

16.7K
An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay09:14

An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay

Published on: January 26, 2019

11.2K

Related Concept Videos

Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
1.9K
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
505
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
2.5K
Common Respiratory Disorders01:31

Common Respiratory Disorders

Respiratory disorders, a prevalent health concern globally, are generally divided into two primary categories: upper and lower respiratory tract disorders. The categorization is based on the area of the respiratory system they affect.
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
1.1K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
621
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
590